Doxorubicin Hydrochloride — Drug Intelligence | 106 EU Trials

Filter these 106 trials by condition, phase, country and more.

Open in Search →

106 Registered trials

54 Recruiting

42 Completed trials

74 Sponsors

24 Countries

Phase III

Phase II

Phase III: 53 Phase II/III: 5 Phase II: 32 Phase I/II: 8 Phase III/IV: 1 Phase IV: 6 Phase I (FiH): 1

Oversight events:

2 serious breaches 2 temporary halts 5 urgent safety measures 6 unexpected events 1 corrective measure across 10 trials

View oversight register →

Indications tested

Diffuse large B-cell lymphoma 9 Ovarian cancer 5 Fallopian tube cancer 4 Follicular lymphoma 4 Endometrial cancer recurrent 3 Soft tissue sarcoma 3 Ovarian epithelial cancer 3 Endometrial cancer 3 Hormone receptor positive breast cancer 3 Triple negative breast cancer 3 Follicle centre lymphoma follicular grade I II III 2 Hepatocellular carcinoma 2

Sponsors using this IMP

Merck Sharp & Dohme LLC 7 AbbVie Deutschland GmbH & Co. KG 4 Genmab A/S 4 Institut Bergonie 3 LYSARC 3 Unicancer 3 University Of Cologne 3 AstraZeneca AB 2 Celgene Corp. 2 Champalimaud Clinical Centre 2 European Organisation For Research And Treatment Of Cancer 2 Fondazione Italiana Linfomi Ets 2

All trials — page 5

106 total

Study to assess the efficacy and safety of alpelisib in combination with olaparib in participants with platinum-resistant or refractory gBRC… Ended

2024-510782-42-00 Phase III 3 countries Novartis Pharma AG
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Ended

2023-503387-16-00 Phase II 4 countries Seagen Inc.
A dual-cohort, open-label, phase 2 study of brentuximab vedotin and CHP (A+CHP) in the frontline treatment of subjects with peripheral T-cel… Ended

2023-509155-14-00 Phase II 3 countries Seagen Inc.
A study to test Mirvetuximab Soravtansine (IMGN853) aganist doctor's choice of cancer medicines in women with advanced Epithelial Ovarian, P… Ended

2024-516111-25-00 Phase III 1 country Immunogen Inc.
A prospective multicenter phase 2 study of copanlisib in combination with rituximab and CHOP chemotherapy (COPA-R-CHOP) in patients with pre… Ended

2024-517166-42-00 Phase II 1 country Universitaetsklinikum Muenster AöR
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Phase III 2 countries NSABP Foundation Inc.
HD21 Ended

2024-518022-33-00 Phase III 6 countries University Of Cologne
Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma Ended

2023-506419-16-00 Phase III 9 countries Takeda Development Center Americas Inc.
A Phase 2 Study of Tremelimumab (Day 1 only), Durvalumab (MEDI4736) and Trans-arterial catheter chemoembolization (TACE)in patients with adv… Ended

2023-510117-26-00 Phase II 1 country University College Dublin
A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fall… Ended

2024-512477-27-00 Phase II 9 countries Sutro Biopharma Inc.

Showing 97–106 of 106 trials

← All drugs A–Z